Apotex is discontinuing chlorpropamide 100 mg and 250 mg tablets in early 2017. The drug belongs to the class of sulfonylureas that are rarely used in Canada. Apotex is the sole manufacturer of chlorpropamide in Canada. Patients should be moved to an alternate therapy.